Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Oreopoulos

Showing results (331-340 of 357) with videos related to

Pageof 36
Sort By:
Transactions - American Society for Artificial Internal Organs|January 1, 1974
Fluoride and dialysis osteodystrophy: results of a double-blind studyD G Oreopoulos, D R Taves, S Rabinovich, et al.
Nephron|January 1, 1982
Experimental model for studies of continuous peritoneal'dialysis in uremic rabbitsL Gotloib, P Crassweller, H Rodella, et al.
The New England Journal of Medicine|June 9, 1977
Epidemic of aseptic peritonitis caused by endotoxin during chronic peritoneal dialysisS Karanicolas, D G Oreopoulos, S Izatt, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1990
Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patientsG E Digenis, G Abraham, E Savin, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)V Calderaro, D G Oreopoulos, H E Meema, et al.
Canadian Medical Association Journal|April 23, 1977
Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periodsD G Oreopoulos, H Husdan, J Harrison, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 29, 2002
Prolonged administration over six hours of large doses of intravenous iron saccharate (500 mg) prevents severe adverse reactions in peritoneal dialysis patientsH K Aggarwal, E Tziviskou, V Bellizzi, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1990
Six-month overnight intraperitoneal amino-acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients--no effect on nutritional statusN V Dombros, K Prutis, M Tong, et al.
Canadian Medical Association Journal|June 19, 1971
Plasma calcitonin in renal osteodystrophyS M Chittal, D G Oreopoulos, G A DeVeber, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
Visceral calcification and the CaXP productC Velentzas, H Meindok, D G Oreopoulos, et al.
Pageof 36

Showing results (331-340 of 357) with videos related to

Sort By:
Pageof 36
Transactions - American Society for Artificial Internal Organs|January 1, 1974
Fluoride and dialysis osteodystrophy: results of a double-blind studyD G Oreopoulos, D R Taves, S Rabinovich, et al.
Nephron|January 1, 1982
Experimental model for studies of continuous peritoneal'dialysis in uremic rabbitsL Gotloib, P Crassweller, H Rodella, et al.
The New England Journal of Medicine|June 9, 1977
Epidemic of aseptic peritonitis caused by endotoxin during chronic peritoneal dialysisS Karanicolas, D G Oreopoulos, S Izatt, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1990
Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patientsG E Digenis, G Abraham, E Savin, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)V Calderaro, D G Oreopoulos, H E Meema, et al.
Canadian Medical Association Journal|April 23, 1977
Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periodsD G Oreopoulos, H Husdan, J Harrison, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 29, 2002
Prolonged administration over six hours of large doses of intravenous iron saccharate (500 mg) prevents severe adverse reactions in peritoneal dialysis patientsH K Aggarwal, E Tziviskou, V Bellizzi, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1990
Six-month overnight intraperitoneal amino-acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients--no effect on nutritional statusN V Dombros, K Prutis, M Tong, et al.
Canadian Medical Association Journal|June 19, 1971
Plasma calcitonin in renal osteodystrophyS M Chittal, D G Oreopoulos, G A DeVeber, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
Visceral calcification and the CaXP productC Velentzas, H Meindok, D G Oreopoulos, et al.
Pageof 36